<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8800104</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3589</journal-id>
<journal-id journal-id-type="nlm-ta">Endocrinol Metab Clin North Am</journal-id>
<journal-id journal-id-type="iso-abbrev">Endocrinol. Metab. Clin. North Am.</journal-id>
<journal-title-group>
<journal-title>Endocrinology and metabolism clinics of North America</journal-title>
</journal-title-group>
<issn pub-type="ppub">0889-8529</issn>
<issn pub-type="epub">1558-4410</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29754632</article-id>
<article-id pub-id-type="pmc">6029257</article-id>
<article-id pub-id-type="doi">10.1016/j.ecl.2018.02.007</article-id>
<article-id pub-id-type="manuscript">NIHMS958691</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Genetics of Cushing’s syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hernández-Ramírez</surname>
<given-names>Laura C.</given-names>
</name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stratakis</surname>
<given-names>Constantine A.</given-names>
</name>
<degrees>MD, D(Med)Sci</degrees>
</contrib>
<aff id="A1">Section on Endocrinology and Genetics (SEGEN), <italic>Eunice Kennedy Shriver</italic> National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH). Bethesda, MD 20892-1862 USA</aff>
</contrib-group>
<author-notes>
<corresp id="FN1">Corresponding author: Constantine A. Stratakis, MD, D(Med)Sci, Section on Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health., 10 Center Drive, CRC, Rm 1E-3216., Bethesda, MD 20892-1862 USA, Phone: +1(301) 402-1998, Fax: +1(301) 402-0574</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>11</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>6</month>
<year>2019</year>
</pub-date>
<volume>47</volume>
<issue>2</issue>
<fpage>275</fpage>
<lpage>297</lpage>
<!--elocation-id from pubmed: 10.1016/j.ecl.2018.02.007-->
<abstract>
<title>Synopsis</title>
<p id="P3">The knowledge on the molecular and genetic causes of Cushing’s syndrome (CS) has greatly increased in the recent years. Somatic mutations leading to overactivation of the 3′,5′-cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) and wingless-type MMTV integration site family (WNT)/beta-catenin (CTNNB1) pathways are the main molecular mechanisms underlying adrenocortical tumorigenesis causing CS. In the pituitary gland, corticotropinomas are characterized by resistance to glucocorticoid negative feedback, dysregulation of pathways controlling cell cycle progression and overexpression of pathways that sustain overactive ACTH production and secretion. Most of the patients with CS present sporadically, while isolated or syndromic familial forms of CS are quite infrequent. Nevertheless, recognizing the germline and somatic genetic defects behind corticotroph and adrenocortical tumorigenesis proves crucial for tailoring the clinical management of the patients and for designing strategies for genetic counselling and clinical screening to be applied in the routine medical practice.</p>
</abstract>
<kwd-group>
<kwd>Cushing’s syndrome</kwd>
<kwd>glucocorticoids</kwd>
<kwd>ACTH</kwd>
<kwd>corticotropinoma</kwd>
<kwd>pituitary adenoma</kwd>
<kwd>adrenal hyperplasia</kwd>
<kwd>cAMP</kwd>
<kwd>
<italic>USP8</italic>
</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>